◄ back to all posts

GSK: GlaxoSmithKline plc Stock

Written by | Jul 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 87,831.16
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-05 13G/A BlackRock Inc. 7.50 9.28

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-10-23 457,150 5,153,700 8.87
2020-10-22 908,351 6,903,700 13.16
2020-10-21 1,059,875 7,760,100 13.66
2020-10-20 950,059 5,306,300 17.90
2020-10-19 558,878 3,487,100 16.03

(click for more detail)

(click for list of largest short owners)

Similar Companies
EBS – Emergent Biosolutions, Inc. ELAN – Elanco Animal Health Inc
FRX – Forest Laboratories Inc HEXO – HEXO Corp.
HSP – Hospira


Financial data and stock pages provided by
Fintel.io


Finpedia: GlaxoSmithKline Pharmaceuticals Ltd




2018/07/06
◄ back to all posts

Retirement